Healthcare -
Biotechnology - NASDAQ - US
$ 6.345
4.75 %
$ 513 M
Market Cap
-3.06
P/E
KURA - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity KURA - Kura Oncology, Inc.
760 M
LAST VALUE
85.12%
2 YEAR CAGR
43.13%
5 YEAR CAGR
88.00%
10 YEAR CAGR